Further Findings

Dr. Kevin Dalby, professor of Medicinal Chemistry, and Scarlett Ferguson, a postdoctoral fellow in the College of Pharmacy, at work in Dalby’s lab. (Marsha Miller)

Cancer researcher Kevin Dalby says he thinks scientists are on track to find a cure for cancer one day.

Make that cures for cancers.

There are so many ways for cells to go bad and become cancerous that anti-cancer therapies will need to include customized agents to modify various cancer-causing targets. Dalby, a professor in the College of
Read More …

Pictured are Kelly Daniels, Christopher Frei, assistant professor, and Julieta Scalo

It takes an average of 24 years for a discovery in a scientist’s laboratory to become a medication at a patient’s bedside.

To speed up that process, the College of Pharmacy at The University of Texas at Austin and three other University of Texas System institutions have begun a Translational Science Ph.D. program to spur communication between the basic scientist and the physician and points in between.

“This program will lead to well-trained
Read More …

Two of The University of Texas at Austin’s significant inventions were highlighted for the Technology Transfer and Research Committee of the University of Texas Systems Board of Regents at an Aug. 24, 2011 meeting.

Richard Miller, chief commercialization officer at The University of Texas at Austin.

Both inventions bring significant benefits to society and revenue to the university, said Richard Miller, the chief commercialization officer of The University of Texas at Austin.

One invention has provided manufacturers with safe, reliable and rechargeable batteries
Read More …